POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 128 participants.
Also called NCT07469722
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 128 participants
- Registry
-
NCT07469722
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07469722. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (anticipated); primary completion 2028-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
- Acronym
- POINTER-HF
- Condition
- Acute Heart Failure (AHF)
- Condition
- Congestive Heart Failure Acute
- Condition
- Diuretic Effect
- Condition
- Lung Ultrasonography Score
- Condition
- Ultrasonography, Doppler
- Condition
- Point-of-care Ultrasound (POCUS)
- Intervention (Drug)
- Furosemide 40 Milligrams.
- Intervention (Drug)
- Furosemide 40 Milligrams.
- Intervention (Drug)
- Hydrochlorothiazide (HCTZ) 25 milligrams.
- Intervention (Drug)
- Acetazolamide 250 milligrams.
- Intervention (Drug)
- Dapagliflozin (10mg Tab)
- Intervention (Drug)
- Potassium Chloride Oral Product
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
Record details
- Record id
cardio:ct-nct07469722- Content hash
6a70acb62405f563de4d53fd520e00fa590f4fa574157873d5fc83004870f188